ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
109.87
-2.03 (-1.81%)
At close: Apr 28, 2026, 4:00 PM EDT
110.75
+0.88 (0.80%)
After-hours: Apr 28, 2026, 5:16 PM EDT
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $8.86 billion as of April 28, 2026. Its market cap has increased by 2,242.57% in one year.
Market Cap
8.86B
Enterprise Value
8.28B
1-Year Change
2,242.57%
Ranking
Category
Stock Price
$109.87
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $8.86B, an increase of 3,829.41%. That is a compound annual growth rate of 40.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 8.98B | -18.40% |
| Dec 31, 2025 | 11.00B | 2,382.10% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arrowhead Pharmaceuticals | 10.35B |
| BioMarin Pharmaceutical | 10.23B |
| Praxis Precision Medicines | 9.60B |
| Axsome Therapeutics | 9.51B |
| Vaxcyte | 8.56B |
| Bio-Techne | 8.48B |
| Nuvalent | 8.22B |
| Cytokinetics | 8.12B |